VANSCHOONBEEK FARMA
ActiveSummary
VANSCHOONBEEK FARMA has been active since 2017 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €250,700 and a net result of €222,740. Equity is growing by about 69% per year across the filed financial years. Its solvency ranks better than 27% of 12,404 sector peers (NACE 47, financial year 2025). The computed 12-month bankruptcy probability is 0.3% (very low).
Financials · financial year 2025, abbreviated format
Equity
€250,700▼ 70.1%
2024 · €837,960
Total assets
€1.5m▼ 11.7%
2024 · €1.7m
Net result
€222,740▼ 0.5%
2024 · €223,942
Working capital
-€331,192
2024 · €329,043
Trend over the years
2021 to 2025, 5 financial years 2018 to 2025, 8 financial years
The operating result falls in 2025; 2025 is 21% below 2024.
What the company sold each financial year and what was left of it. A loss stands below the zero line.
Operating result€0.2m
2025
Net result€0.2m
2025
What the company owns (total assets), how much of it is its own (equity) and how much it owes.
Total assets€1.5m
2025
Equity€0.3m
2025
Debt€1.3m
2025
Short-term assets minus short-term debts. Above zero the company can pay its bills in the short term.
Working capital-€0.3m
2025
How much of each euro of turnover is left from operations (EBIT margin) and what the assets earn (return on assets).
Return on assets (ROA)14.8%
2025
The share of the company financed with its own means. The higher it is, the better it absorbs a shock.
Solvency16.7%
2025
Short-term assets per euro of short-term debt. Above 1 the short-term debts are covered.
Current ratio0.47
2025
Use the arrow keys on the chart for the figures per year.
Sector: the middle half of NACE 47, Retail trade: a quarter of companies sit below it, a quarter above. Each year compared with accounts in the same format, and only where there are at least 30. Dashed line: the median. Available for Net result, Equity, Total assets, Working capital, Solvency, Current ratio, Return on assets (ROA).
Every figure with its change against the financial year before
favourable
unfavourable
Line20182019202020212022202320242025
Operating result€0.03m-€0.02m▼ 32.9%€0.06m▲ 196%€0.2m▲ 152%€0.3m▲ 99.0%€0.3m▼ 6.2%€0.3m▲ 1.5%€0.2m▼ 21.1%
Net result€0.02m-€0.02m▼ 27.9%€0.04mwithin the sector's middle half▲ 158%€0.1mwithin the sector's middle half▲ 156%€0.2mabove the sector's middle half▲ 106%€0.2mabove the sector's middle half▼ 6.6%€0.2mabove the sector's middle half▲ 1.8%€0.2mabove the sector's middle half▼ 0.5%
Equity€0.04m-€0.05m▲ 47.5%€0.1mwithin the sector's middle half▲ 83.2%€0.2mwithin the sector's middle half▲ 116%€0.4mabove the sector's middle half▲ 92.6%€0.6mwithin the sector's middle half▲ 50.1%€0.8mabove the sector's middle half▲ 36.5%€0.3mwithin the sector's middle half▼ 70.1%
Total assets€0.04m-€0.06m▲ 28.9%€1.2mwithin the sector's middle half▲ 2,008%€1.3mwithin the sector's middle half▲ 5.3%€1.4mabove the sector's middle half▲ 14.2%€1.5mwithin the sector's middle half▲ 4.6%€1.7mwithin the sector's middle half▲ 13.1%€1.5mabove the sector's middle half▼ 11.7%
Debt€0.008m-€0.003m▼ 60.1%€1.1m▲ 35,998%€1.0m▼ 4.6%€1.0m▼ 1.7%€0.9m▼ 13.5%€0.9m▼ 3.0%€1.3m▲ 45.0%
Working capital€0.03m-€0.05m▲ 49.9%-€0.07mbelow the sector's middle half-€0.03mbelow the sector's middle half▲ 59.7%€0.1mabove the sector's middle half€0.2mwithin the sector's middle half▲ 130%€0.3mwithin the sector's middle half▲ 43.8%-€0.3mbelow the sector's middle half
Solvency82.7%-94.6%▲ 11.9pp8.2%below the sector's middle half▼ 86.4pp16.9%below the sector's middle half▲ 8.7pp28.5%within the sector's middle half▲ 11.6pp40.8%within the sector's middle half▲ 12.4pp49.3%within the sector's middle half▲ 8.4pp16.7%within the sector's middle half▼ 32.6pp
Current ratio5.24-23.37▲ 18.130.27below the sector's middle half▼ 23.100.76below the sector's middle half▲ 0.491.59within the sector's middle half▲ 0.833.16above the sector's middle half▲ 1.573.18above the sector's middle half▲ 0.020.47below the sector's middle half▼ 2.71
Return on assets (ROA)54.5%-30.5%▼ 24.0pp3.7%within the sector's middle half▼ 26.8pp9.1%within the sector's middle half▲ 5.3pp16.4%above the sector's middle half▲ 7.3pp14.6%above the sector's middle half▼ 1.8pp13.2%above the sector's middle half▼ 1.5pp14.8%above the sector's middle half▲ 1.7pp
above
within
below
the middle half of NACE 47, Retail trade: a quarter of companies sit below it, a quarter above. Each year compared with accounts in the same format, and only where there are at least 30.
Turnover and EBIT margin not published: the abbreviated or micro format does not require them.
Why a figure moved sharply
- 2022 Net result +106% on 2021. The accounts now follow the micro format, last year the abbreviated format.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €1.5m
Fixed assets
€1.2m ▼ 1.0%
Current assets
€293,572 ▼ 38.9%
Equity and liabilities €1.5m
Equity
€250,700 ▼ 70.1%
Debt
€1.3m ▲ 45.0%
Debt's share of the balance-sheet total rises from 50.7% to 83.3%. Equity is lower and debt is higher.
Key figures and ratios
EBITDA
€254,611▼
2024 · €312,390
Cash flow
€234,796▲
2024 · €228,828
Debt to equity
4.99▲
2024 · 1.03
ROE
88.8%▲
2024 · 26.7%
Interest coverage
19.74▼
2024 · 20.80
Debt ≤ 1 year
€624,764▲
2024 · €151,197
Debt > 1 year
€623,493▼
2024 · €699,859
Income taxes
€52,915▼
2024 · €68,546
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Annual accounts
| Line | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|---|---|---|
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630 | €722 | €1,118 | €1,118 | €1,350 | €1,650 | €1,764 | €4,886 | €12,055 | ▲ 147% |
| Other operating charges640/8 | - | - | - | €348 | €868 | €960 | €1,162 | €1,141 | ▼ 1.8% |
| Gross operating margin9900 | €33,782 | €23,701 | €65,858 | €163,873 | €325,234 | €305,566 | €313,553 | €255,752 | ▼ 18.4% |
| Operating profit (loss)9901 | €32,365 | €21,726 | €64,342 | €162,175 | €322,716 | €302,841 | €307,505 | €242,556 | ▼ 21.1% |
| Financial income75/76B | - | - | - | - | - | - | - | €46,000 | - |
| Recurring financial income75 | - | - | €0 | - | - | - | - | €46,000 | - |
| Financial charges65/66B | - | - | - | €16,083 | €15,306 | €16,195 | €15,017 | €12,900 | ▼ 14.1% |
| Recurring financial charges65 | €45 | €36 | €8,477 | €16,083 | €15,306 | €16,195 | €15,017 | €12,900 | ▼ 14.1% |
| Profit (loss) for the period before taxes9903 | €32,320 | €21,690 | €55,865 | €146,092 | €307,410 | €286,646 | €292,488 | €275,655 | ▼ 5.8% |
| Income taxes67/77 | €8,367 | €4,410 | €11,234 | €31,995 | €71,946 | €66,651 | €68,546 | €52,915 | ▼ 22.8% |
| Profit (loss) for the period9904 | €23,953 | €17,279 | €44,631 | €114,097 | €235,463 | €219,995 | €223,942 | €222,740 | ▼ 0.5% |
| Profit (loss) for the period to be appropriated9905 | €23,953 | €17,147 | €44,631 | €114,097 | €235,463 | €219,995 | €223,942 | €222,740 | ▼ 0.5% |
| Line | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||
| Total assets20/58 | €0.04m | €0.06m | €1.2m | €1.3m | €1.4m | €1.5m | €1.7m | €1.5m | ▼ 11.7% |
| Fixed assets21/28 | €0.004m | €0.006m | €1.2m | €1.2m | €1.2m | €1.2m | €1.2m | €1.2m | ▼ 1.0% |
| Tangible fixed assets22/27 | €0.004m | €0.006m | €0.005m | €0.005m | €0.004m | €0.004m | €0.06m | €0.04m | ▼ 21.5% |
| Plant, machinery and equipment23 | - | - | - | - | - | €0.002m | €0.002m | €0.002m | ▼ 11.7% |
| Furniture and vehicles24 | - | - | - | €0.005m | €0.004m | €0.002m | €0.05m | €0.04m | ▼ 21.9% |
| Financial fixed assets28 | - | - | €1.2m | €1.2m | €1.2m | €1.2m | €1.2m | €1.2m | = |
| Current assets29/58 | €0.04m | €0.05m | €0.03m | €0.09m | €0.3m | €0.3m | €0.5m | €0.3m | ▼ 38.9% |
| Amounts receivable within one year40/41 | €0.007m | €0.008m | €0.001m | €0.001m | €0.002m | €0.04m | €0.3m | €0.2m | ▼ 15.8% |
| Trade receivables40 | - | - | - | €130 | - | - | €0.2m | €0.1m | ▼ 54.5% |
| Other amounts receivable41 | - | - | - | €0.001m | €0.002m | €0.04m | €0.04m | €0.1m | ▲ 222% |
| Cash at bank and in hand54/58 | €0.03m | €0.04m | €0.02m | €0.09m | €0.3m | €0.3m | €0.2m | €0.05m | ▼ 72.6% |
| Deferred charges and accrued income490/1 | - | - | - | €475 | €475 | €342 | €0.001m | €0.001m | ▼ 0.3% |
| Equity and liabilities | |||||||||
| Total equity and liabilities10/49 | €0.04m | €0.06m | €1.2m | €1.3m | €1.4m | €1.5m | €1.7m | €1.5m | ▼ 11.7% |
| Equity10/15 | €0.04m | €0.05m | €0.1m | €0.2m | €0.4m | €0.6m | €0.8m | €0.3m | ▼ 70.1% |
| Contributions10/11 | €0.01m | €0.01m | - | €0.01m | €0.02m | €0.02m | €0.02m | €0.02m | = |
| Reserves13 | €0.02m | €0.04m | €0.09m | €0.2m | €0.4m | €0.6m | €0.8m | €0.2m | ▼ 71.7% |
| Non-distributable reserves130/1 | - | - | - | €0.002m | - | - | - | - | - |
| Reserves not available under the articles1311 | - | - | - | €0.002m | - | - | - | - | - |
| Tax-exempt reserves132 | - | - | - | €132 | €132 | €132 | €132 | €132 | = |
| Distributable reserves133 | - | - | - | €0.2m | €0.4m | €0.6m | €0.8m | €0.2m | ▼ 71.7% |
| Profit (loss) carried forward14 | - | - | - | - | - | €0 | €0 | €0 | - |
| Amounts payable17/49 | €0.008m | €0.003m | €1.1m | €1.0m | €1.0m | €0.9m | €0.9m | €1.3m | ▲ 45.0% |
| Amounts payable after more than one year17 | - | - | €1.0m | €0.9m | €0.8m | €0.8m | €0.7m | €0.6m | ▼ 10.9% |
| Financial debts170/4 | - | - | - | €0.9m | €0.8m | €0.8m | €0.7m | €0.6m | ▼ 10.9% |
| Amounts payable within one year42/48 | €0.008m | €0.002m | €0.09m | €0.1m | €0.2m | €0.1m | €0.2m | €0.6m | ▲ 313% |
| Current portion of amounts payable after more than one year42 | - | - | - | €0.07m | €0.07m | €0.07m | €0.08m | €0.08m | ▲ 1.5% |
| Financial debts43 | - | - | - | €0.009m | €0.04m | €0.03m | €0.03m | €0.02m | ▼ 19.5% |
| Credit institutions430/8 | - | - | - | €0.009m | €0.04m | €0.03m | €0.03m | €0.02m | ▼ 19.5% |
| Trade debts44 | €0.006m | €0.001m | - | €0.002m | €114 | €0.001m | €0 | €0.006m | - |
| Suppliers440/4 | - | - | - | €0.002m | €114 | €0.001m | €0 | €0.006m | - |
| Taxes, remuneration and social security45 | - | - | - | €0.01m | €0.003m | €0.003m | €0.05m | €0.03m | ▼ 29.0% |
| Taxes450/3 | - | - | - | €0.01m | €0.003m | €0.003m | €0.05m | €0.03m | ▼ 29.0% |
| Other amounts payable47/48 | - | - | - | €0.02m | €0.05m | €0.003m | €0.002m | €0.5m | ▲ 22,539% |
| Accrued charges and deferred income492/3 | - | - | - | €0.007m | €0.009m | €0.008m | €0.01m | €0.003m | ▼ 75.8% |
| Line | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|---|---|---|
| Profit (loss) for the period9904 | €0.02m | €0.02m | €0.04m | €0.1m | €0.2m | €0.2m | €0.2m | €0.2m | ▼ 0.5% |
| + Depreciation and write-downs630 | €0.001m | €0.001m | €0.001m | €0.001m | €0.002m | €0.002m | €0.005m | €0.01m | ▲ 147% |
| Operating cash flow (approximation) | €0.02m | €0.02m | €0.05m | €0.1m | €0.2m | €0.2m | €0.2m | €0.2m | ▲ 2.6% |
| Investment in fixed assets (approximation) | - | -€0.003m | -€1.2m | -€0.002m | €0 | -€0.002m | -€0.06m | €0 | - |
| Change in cash | - | €0.01m | -€0.02m | €0.06m | €0.2m | €0.03m | -€0.1m | -€0.1m | ▼ 37.6% |
Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.
Filings with the National Bank (8)
| Financial year | Type | Filed | Reference |
|---|---|---|---|
| 31-12-2025 | abbreviated format | 08-06-2026 | 2026-00153610 |
| 31-12-2024 | abbreviated format | 22-07-2025 | 2025-00294855 |
| 31-12-2023 | abbreviated format | 22-08-2024 | 2024-00365384 |
| 31-12-2022 | micro format | 30-08-2023 | 2023-00381076 |
| 31-12-2021 | abbreviated format | 25-07-2022 | 2022-20222410 |
| 31-12-2020 | abbreviated format | 11-08-2021 | 2021-47900487 |
| 31-12-2019 | abbreviated format | 23-07-2020 | 2020-34900459 |
| 31-12-2018 | abbreviated format | 26-07-2019 | 2019-39400452 |
Similar companies · same sector, comparable size
PHARMACIE RONDEAU
BE 0447.088.737
Frameries · equity €250,651
APOTHEEK VAN REETH - DEPROST
BE 0455.125.384
Antwerpen · equity €251,034
Apotheek Schuttershof
BE 0878.869.290
Scherpenheuvel-Zichem · equity €251,179
APOTHEEK K. HEIRBAUT
BE 0427.407.536
Temse · equity €250,078
PROPHARMA
BE 0645.717.815
Ottignies-Louvain-la-Neuve · equity €250,000
Of the 5,203 active companies whose main activity is retail sale of pharmaceutical products (NACE 47730), figures are known for 3,876. 3,536 are within a factor 10 of this equity. These 5 are the closest to it. See the whole sector
Subsidies and aid
Flemish government
2023 to 2025 · 3 entries · €361 awarded · €361 paid| Year | Entries | Awarded | Paid |
|---|---|---|---|
| 2025 | 1 | €104 | €104 |
| 2024 | 1 | €92 | €92 |
| 2023 | 1 | €165 | €165 |
Public contracts: No European public contracts awarded found since October 2016. Contracts below the EU thresholds are not in TED.